Connection

ANNA MANDALAKAS to Diarylquinolines

This is a "connection" page, showing publications ANNA MANDALAKAS has written about Diarylquinolines.
Connection Strength

1.054
  1. Emerging bedaquiline-resistant tuberculosis. Lancet Microbe. 2023 12; 4(12):e964-e965.
    View in: PubMed
    Score: 0.811
  2. Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing. Nat Commun. 2026 Jun 11; 17(1).
    View in: PubMed
    Score: 0.243
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.